Recent studies have shown that several PDIs, such as PDIA1, PDIA3 and PDIA6, are upregulated in different cancer types, including kidney, lung, brain, ovarian, melanoma, prostate and male germ-cell tumours, and over-expression of PDIs may serve as a diagnostic marker for cancer [11,15,17,18]. This evidence concerns the gene PDIA3 and cancer.